Health Condition 1: N74- Female pelvic inflammatory disorders in diseases classified elsewhere Health Condition 2: null- Pelvic Inflammatory Disease
Conditions
Interventions
Intervention1: tukhme katan (3 gm) and tukhme isapghol (3 gm) with honey (5 ml): Orally placebo will be given for 14 days. Locally per vaginum powder of tukhme katan (3 gm) and tukhme isapghol (3 gm)
Sponsors
National Institue of Unani mediicne
Eligibility
Inclusion criteria
Inclusion criteria: 1. Married women aged from 18-45 years. 2. Women diagnosed with clinical features of waram al-rahim (adnexal and cervical motion tenderness, pelvic discomfort, lower abdominal pain, abnormal vaginal discharge, low backache, dyspareunia, dysuria)1 and other clinical features of uPID (mild/subclinical PID).
Exclusion criteria
Exclusion criteria: 1. Pregnant or lactating or had complicated PID (pelvic or tubo-ovarian abscess) and/or any condition likely to require surgical intervention within 24 hours of the start of treatment. 2. Systemic antibacterial therapy 3. History of cardiovascular abnormalities, epilepsy, impaired liver and renal function 4. A history of uterine or pelvic or abdominal surgery 5. Intolerance to or inability to follow an oral antibiotic regimen 6. Delivery and abortion within last three months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome: Change in McCormack pain scale and VAS pain scale.Timepoint: Pretest and posttest | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcome: Change in health related quality of life assessed by SF-12. Timepoint: At baseline (Zero day) and post test on 15th day | — |
Countries
India
Contacts
Public ContactDr Arshiya Sultana
National Institute of Unani Medicine
Outcome results
None listed